Soft, smooth, healthy skin is coveted at every age. But if you are one of the millions of people who suffer from non-melanoma skin cancer or unsightly keloid scarring, you may be self-conscious about your appearance and feel like you have to keep your skin covered.

Now there’s a non-surgical treatment that could be right for you—the SRT-100™by Sensus Healthcare.

Using a precise, calibrated dose of Superficial Radiotherapy (SRT) that only penetrates five millimeters below the skin’s surface, this minimally invasive treatment effectively removes both basal and squamous cell carcinoma (non-melanoma skin cancer), and unattractive keloids. Feel confident about your skin with the SRT-100™.

Skin cancer is on the rise. Nearly four million people are diagnosed with basal and squamous cell carcinoma (non-melanoma skin cancer) each year in the United States. If you’re one of them, you know traditional treatments like Mohs surgery are often used. While surgery is an appropriate option, there are times when a non-surgical alternative like SRT is desired. This amazing non-surgical treatment delivers a remarkable cure rate-98 percent for non-melanoma skin cancer.

Performed right in the doctor’s office, each treatment is painless and only takes a few minutes. The SRT-100™ can be used to treat lesions on the arms, legs, back and trunk. It works especially well on skin cancers located on the head and neck where nearly 80 percent of all skin cancer occurs-especially along the fold of the nose, eyelids, lips, corner of the mouth and the lining of the ear.

KELOID TREATMENT THAT RESTORES YOUR SKIN’S SENSUAL BEAUTY.

For nearly 11 million people afflicted by these unsightly and sometimes painful growths, keloids don’t just scar the skin; they can scar a person’s confidence. The SRT-100™ by Sensus Healthcare is giving countless keloid sufferers new hope and confidence.

Whether you suffer from keloids caused by surgery, acne, chicken pox, piercing or burns, the SRT-100™ can help rid you of these non-malignant tumors caused by skin trauma. The SRT-100™ is also a good treatment option for individuals who are genetically prone to keloids-including African Americans, Latinos and Asians. In fact, patients who undergo treatment with the SRT-100™ after excision of the scar tisue enjoy cure rates of 95% and higher.

ENJOY SENSATIONAL BENEFITS

With cure ratessimilar to surgery, the SRT-100™ provides patients and physicians with safe and effective basal cell and squamous cell carcinoma treatment. The SRT-100™ offers many